We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glenmark Lobs Counterclaims At Teva In Coreg Suit

Law360 (December 2, 2008, 12:00 AM EST) -- Glenmark Pharmaceuticals Ltd. has moved into an offensive position in a patent spat over the preparation of a generic version of congestive heart failure treatment Coreg, accusing Teva Pharmaceuticals Industries Ltd....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.